Cannabis Production

Search documents
Top 3 Canadian Cannabis Stocks to Watch in October 2025
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-10-11 14:00
Top Canadian Weed Stocks to Watch Now as U.S. Reform ApproachesThe Canadian cannabis sector continues to attract investors as North American legalization momentum gains strength. Recently, U.S. regulators advanced discussions on cannabis rescheduling, signaling a potential shift toward federal reform. This news lifted optimism across the industry, especially for Canadian producers eyeing future U.S. market entry. Currently, the U.S. cannabis market generates over $35 billion in annual sales and is projected ...
Hot stocks: Canada’s top performers in Q3 2025
MoneySense· 2025-10-02 04:56
Group 1: Stock Performance - Bitfarms Ltd. was the top-performing stock with a 247.8% return over 90 days ending September 30, followed by Curaleaf Holdings Inc. at 233% and Energy Fuels Inc. at 171.5% [1][3] - The S&P/TSX Composite index gained 11.8% during the same period, with a total return of 12.5% including dividends, outperforming the S&P 500 which returned 7.8% [2] Group 2: Sector Highlights - Notable sectors contributing to stock performance included technology, cannabis, uranium, fast fashion, and gold, indicating a preference for riskier investments [3] - Bitfarms' growth was attributed to rising bitcoin values and increased demand for data centers driven by the AI boom, with a reported 87% year-over-year revenue increase in Q2 [3] - Curaleaf's stock was positively impacted by its inclusion in the S&P/TSX Composite and supportive social media posts from U.S. President Donald Trump regarding cannabis legalization [4] Group 3: Company Insights - Energy Fuels' growth was fueled by rising uranium prices and U.S. government initiatives to enhance nuclear energy supply chains, alongside its involvement in rare earth elements [5] - Cresco Labs Inc. emerged as a top performer, starting the quarter as a penny stock, highlighting the volatility and potential in the cannabis sector [3] Group 4: Momentum Investing - The article notes that a strong performance over a short period does not guarantee future gains, especially for smaller or unprofitable companies in volatile sectors, but momentum investing has historically shown positive results [5][6] - There is no consensus on the optimal holding period for stocks to continue appreciating, with opinions varying from a few months to over a year [5]
Markets Keep at All-Time Highs - Lots of Data Expected This Week
ZACKS· 2025-09-29 23:05
Market Performance - Market indexes experienced gains, with the Dow up +68 points, S&P 500 gaining +17 points, and Nasdaq increasing +107 points, while the Russell 2000 rose +2 points [2] - The market was influenced by a government shutdown threat and OPEC+'s decision to raise oil production by 137K barrels per day, leading to a -3.8% drop in WTI prices and a -2.5% decline in Exxon Mobil and BP stocks [1] Housing Market - Pending Home Sales rose by +4.0% in August, surpassing expectations and reversing a previous downward trend, aided by slightly easing mortgage rates [3] - Newly-built homes also saw an increase, with homebuilder stocks like Lennar, Pulte Home, and KB Home rising more than +1% due to pent-up demand [4] Cannabis Industry - The Trump administration is considering reclassifying cannabis from Schedule I to Schedule III, which could have significant implications for the industry, resulting in a +60% increase in Tilray's stock price [5] Economic Data Expectations - Upcoming economic data includes Case-Shiller Home Prices, Chicago Business Barometer, and Consumer Confidence, with expectations for slight increases and a narrowing in Consumer Confidence to 95.8 [6] - The Job Openings and Labor Turnover Survey (JOLTS) is expected to show a decrease in job openings to 7.1 million, the lowest since September 2024 [7] Company Earnings - Nike is set to report fiscal Q1 earnings, with expectations of a -60% year-over-year earnings decline and -4.95% revenue drop, despite having outperformed earnings expectations for eight consecutive quarters [8][9]
CANPR Technology Ltd. Announces Director Nominations for Upcoming Shareholder Meeting, Adoption of Advance Notice By-Law
Newsfile· 2025-09-19 10:39
Core Points - CANPR Technology Ltd. will hold its annual general and special meeting of shareholders on October 24, 2025, at 11:00 a.m. Toronto time [1] - The board has nominated three incumbents and three new nominees for election as directors, while two current directors will not seek re-election [2] - The company has adopted an Advance Notice By-law to ensure shareholders receive adequate notice regarding director nominations [10][11] Company Updates - The nominated incumbents are Stephen Smith, Dexter John, and Akshat Soni, while the new nominees are Travis Kanellos, Jay Wilgar, and Ungad Chadda [2] - Ted Hastings and Uppekha Jain will not be seeking re-election, and the company appreciates their contributions [3] - Akshat Soni, CEO, expressed excitement about the new nominees, highlighting their expertise in scaling platforms and governance [3] New Board Members' Profiles - Travis Kanellos has over 16 years of experience in technology, cannabis, and vertical farming, co-founding CanPR Technology Inc. and achieving over 1 million app downloads [4][5] - Jay Wilgar was the founder and CEO of Newstrike Brands Ltd., overseeing its growth and acquisition for over $300 million [6][8] - Ungad Chadda has extensive experience in capital markets and has held senior roles at TMX Group, contributing to various public company boards [9] By-Law Details - The Advance Notice By-law requires shareholders to provide notice for director nominations 30 days before an annual meeting or 10 days after a public announcement if less than 60 days' notice is given [11] - The By-law takes effect immediately but requires shareholder ratification at the upcoming meeting [12] Company Overview - CanPR Technology Ltd. is a leader in Canadian immigration administration, providing digital solutions to simplify the newcomer journey [13]
Organigram (OGI) - 2025 Q3 - Earnings Call Transcript
2025-08-13 13:00
Financial Data and Key Metrics Changes - In Q3 fiscal 2025, gross sales increased by 73% year over year and 7.2% sequentially, reaching a record $110.2 million [28] - Net revenue also reached a record high, growing 72% year over year and 7.9% sequentially to $70.8 million [28] - Adjusted EBITDA for the quarter was $5.7 million, a 64% increase year over year [34] - Net loss for the quarter was $6.3 million compared to net income of $2.8 million in the prior year period [35] - Cash flow from operations was $14.6 million, a significant improvement from cash used of $3.7 million in the prior year [35] Business Line Data and Key Metrics Changes - Organigram maintained its position as the number one licensed producer in Canada with an 11.6% market share, leading in pre-rolls and vapes [7] - In the vape segment, Organigram held a 20.4% market share, while in the pre-roll segment, it held 8.3% [7] - The company achieved its highest edibles market share of 18.2% in the last twelve months [11] - International revenue reached $7.4 million, a 208% year over year increase [22] Market Data and Key Metrics Changes - The Canadian recreational cannabis market grew by 6.6% year over year, reaching $1.4 billion in retail sales [7] - Organigram's market share in flower increased to 10.6%, up 60 basis points from Q2 [7] - The beverage market share held by Organigram was 6.2% as of June [12] Company Strategy and Development Direction - The company is focused on balancing domestic and international market demands while expanding its product offerings [27] - Organigram is enhancing its operational capacity and efficiency, with significant investments in its facilities [16][20] - The company is optimistic about the long-term potential of the cannabis beverage market, especially with favorable regulatory changes in Canada [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a gross margin of approximately 35% for the full year, driven by seasonal throughput and synergies from the Motif acquisition [41][43] - The company remains cautious about shifting too much supply to international markets at the expense of domestic brands [29] - Management highlighted ongoing improvements in operational efficiency and the potential for margin expansion in the coming quarters [34][31] Other Important Information - The company is awaiting EU GMP certification, which is expected to enhance international sales and margins [26][56] - Management noted that approximately 27% of Moncton's harvest was seed-based, contributing to lower production costs [26] Q&A Session Summary Question: Outlook on gross margins and expected expansion - Management confirmed the expectation of a 35% average gross margin for the year, driven by seasonal throughput and synergies from the Motif acquisition [41][43] Question: Cultivation capacity and balancing domestic vs international demand - Management discussed ongoing capacity expansion projects and the reevaluation of previous investment plans to optimize production for both domestic and international markets [45][48] Question: Timing and impact of EU GMP certification - Management indicated that while the timing of the certification is uncertain, it will significantly enhance margins and reduce delays in product delivery [56][58] Question: Investment opportunities in the U.S. and potential federal reform - Management expressed excitement about the U.S. market but emphasized that current focus remains on international markets due to existing legal frameworks [66][67]
3 Marijuana Stocks For Long-term Profits In The Cannabis Sector
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-07-16 15:08
Industry Overview - The legal cannabis industry in the USA has faced a continuous downtrend, with many marijuana stocks falling significantly, leading to challenges in profit-taking for investors [1] - Shareholders are adopting a long-term strategy, hoping for federal legalization and banking reforms to enhance the safety of their investments [2] - Speculation around better reforms and opportunities in international markets like Canada and Europe is driving interest in the cannabis sector [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products. Recently partnered with Redemption Cannabis to launch products in West Virginia [4][5] - **Curaleaf Holdings, Inc.**: Engaged in the production and distribution of cannabis products both domestically and internationally. Scheduled to report Q2 2025 financial earnings on August 6, 2025 [5][8] - **Cresco Labs Inc.**: Cultivates and sells retail and medical cannabis products. Recently changed its auditor from Marcum LLP to Baker Tilly US, LLP, with shareholder ratification planned for the next annual meeting [9] Stocks to Watch - Top marijuana stocks identified for potential investment include Trulieve Cannabis Corp., Curaleaf Holdings, Inc., and Cresco Labs Inc. [6]
Best Canadian Marijuana Stocks for U.S. Market Exposure
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-05-13 14:00
Industry Overview - The U.S. cannabis industry is projected to reach approximately $45 billion by 2025 and over $75 billion by 2030, driven by federal reform discussions and expanding legalization [1][2] - Canadian cannabis companies are strategically positioning themselves for growth in the U.S. market through acquisitions and partnerships [1][2] Company Highlights Tilray Brands Inc. - Tilray operates in Canada, Europe, and the U.S., focusing on wellness and beverage sectors, distributing THC-infused beverages in over 10 U.S. states [3][5] - In Q3 fiscal 2025, Tilray reported revenue of $185.8 million, with a gross profit of $52 million, marking a 5% increase in gross margin to 28% [7][8] - Despite a net loss of $793.5 million primarily due to non-cash impairment charges, Tilray reduced its overall debt by $76 million, indicating a commitment to financial sustainability [8] Canopy Growth Corporation - Canopy Growth, a prominent cannabis producer in Canada, has shifted its U.S. strategy through Canopy USA, allowing it to engage with American operators while adhering to federal laws [9][11] - The company reported Q3 fiscal 2025 revenue of $74.8 million, a 5% decline year-over-year, but an 8% increase when excluding divested businesses [12][13] - Canopy's medical cannabis business in Canada remains strong, and the company prepaid a $100 million loan to improve cash flow and reduce interest costs [13] Village Farms International Inc. - Village Farms transitioned from greenhouse vegetable growing to cannabis production through its Pure Sunfarms subsidiary, focusing on wellness-based expansion in the U.S. [14][16] - In Q1 2025, Village Farms reported consolidated revenue of $77.1 million, slightly down from $78.1 million the previous year, but its Canadian cannabis segment achieved a net income of $3 million, a 258% increase [17][18] - The company plans to privatize part of its produce business to concentrate resources on its cannabis operations, which is expected to unlock more value [18] Investment Outlook - Canadian cannabis companies like Tilray, Canopy, and Village Farms are actively restructuring operations and improving balance sheets to capture growth in the U.S. market [19][20] - Each company has shown improvements in key financial metrics, with Tilray leading in beverages, Canopy leveraging brand strength, and Village Farms excelling in operational efficiency [20]
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
GlobeNewswire News Room· 2025-05-04 17:01
Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time and has consistently ranked highly in securities class action settlements [4] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4]